In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history hav

Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers.

Binge-drinkers are being warned their behaviour could make them worse in bed.

They lower cholesterol and heart attack risk and may hold promise against other diseases, including cancer. Doctors consider broadening their use.

A study published December 18 in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.

Is alcohol a tonic or a toxin? The question is especially critical to older people, whose overall medical picture gives alcohol the potential to be a health benefit or a life-shortening hazard.

People who are depressed are literally sick at heart: they have a significantly increased risk for cardiovascular disease, and no one knows exactly why. Now three new studies have tried to explain this, and they arrive at subtly different conclusions.&

Low-income men are more likely to present with advanced prostate cancers, most likely because they don't receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.

Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades. In a study scheduled for publication in the Februa

Study: Saw Palmetto No Better Than Fake Drug for Enlarged Prostate

Just under five per cent of the men who took part in the prostate cancer element of the USA's largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes, according to research pu

In patients with locally advanced or high-risk prostate cancer, combining prostate radiotherapy with the conventional endocrine (hormone) treatment halves mortality. Thus endocrine treatment plus radiotherapy should be the new standard. These are the c

Government advisers rejected on Thursday Merck's bid for over-the-counter sales of Mevacor, the cholesterol-lowering drug.

Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. While a 2006 report from

Drug Combo for Hypertension May Be Safer Than Recommended Alternative

Researchers Find Poor Use of Pumps for Ailing Hearts

Moving the clock ahead in the spring provides a pleasant extra hour of sunlight at the end of the day, but according to Swedish researchers it may have an unpleasant side effect: an increase in heart attacks.

A Call for Caution in the Rush to Statins

A large new study seems to suggest that millions of people with low cholesterol could benefit from taking the cholesterol-lowering drugs known as statins. That would be a boon for some drug companies, but whether it would be good for all patients remai

Heart attack and heart failure patients have a higher risk of a second heart attack or death if they take painkillers, including the generic drug ibuprofen and Celebrex, made by Pfizer, a Danish study has found.